Middle East & Africa Acute Repetitive Seizures Market Size & Outlook
Related Markets
MEA acute repetitive seizures market highlights
- The MEA acute repetitive seizures market generated a revenue of USD 84.5 million in 2024.
- The market is expected to grow at a CAGR of 13% from 2025 to 2030.
- In terms of segment, usl-261 was the largest revenue generating drug class in 2024.
- AZ-002 is the most lucrative drug class segment registering the fastest growth during the forecast period.
- Country-wise, UAE is expected to register the highest CAGR from 2025 to 2030.
MEA data book summary
| Market revenue in 2024 | USD 84.5 million |
| Market revenue in 2030 | USD 175.9 million |
| Growth rate | 13% (CAGR from 2025 to 2030) |
| Largest segment | Usl-261 |
| Fastest growing segment | AZ-002 |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | USL-261, NRL-1, AZ-002, Diastat |
| Key market players worldwide | UCB SA, Neurelis, Bausch Health Companies Inc, Alexza Pharmaceuticals, Veritone Inc |
Other key industry trends
- In terms of revenue, MEA region accounted for 2.7% of the global acute repetitive seizures market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,464.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Acute Repetitive Seizures Market Scope
Acute Repetitive Seizures Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Alexza Pharmaceuticals | View profile | 51-100 | Mountain View, California, United States, North America | http://www.alexza.com |
| Neurelis | View profile | 101-250 | Encinitas, California, United States, North America | http://www.neurelis.com/ |
| Veritone Inc | View profile | 696 | 1615 Platte Street, 2nd Floor, Denver, CO, United States, 80202 | https://www.veritone.com |
| Bausch Health Companies Inc | View profile | 20270 | 2150 Saint Elzear Boulvard West, Laval, QC, Canada, H7L 4A8 | https://www.bauschhealth.com |
| UCB SA | View profile | 9083 | Allee de la Recherche, 60, Brussels, Belgium, B-1070 | https://www.ucb.com |
Middle East & Africa acute repetitive seizures market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to acute repetitive seizures market will help companies and investors design strategic landscapes.
Usl-261 was the largest segment with a revenue share of 44.5% in 2024. Horizon Databook has segmented the Middle East & Africa acute repetitive seizures market based on usl-261, nrl-1, az-002, diastat covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Middle East & Africa acute repetitive seizures market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa acute repetitive seizures market databook
-
Our clientele includes a mix of acute repetitive seizures market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa acute repetitive seizures market, including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa acute repetitive seizures market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
MEA acute repetitive seizures market size, by country, 2018-2030 (US$M)
Middle East & Africa Acute Repetitive Seizures Market Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
